Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
skin and connective tissue diseases | D017437 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RETIN-A | Bausch Health Companies | N-017955 RX | 1982-01-01 | 1 products, RLD, RS |
RETIN-A | Bausch Health Companies | N-019049 RX | 1988-09-16 | 1 products, RLD, RS |
RETIN-A MICRO | Bausch Health Companies | N-020475 RX | 1997-02-07 | 2 products, RLD, RS |
RETIN-A-MICRO | Bausch Health Companies | N-020475 RX | 2014-01-28 | 2 products, RLD, RS |
ALTRENO | Dow Pharmaceutical Sciences | N-209353 RX | 2018-08-23 | 1 products, RLD, RS |
ATRALIN | Dow Pharmaceutical Sciences | N-022070 RX | 2007-07-26 | 1 products, RLD, RS |
AVITA | Mylan | N-020404 RX | 1997-01-14 | 1 products |
RETIN-A | Bausch Health Companies | N-017522 RX | 1982-01-01 | 1 products, RLD, RS |
RETIN-A | Bausch Health Companies | N-017579 RX | 1982-01-01 | 1 products, RLD, RS |
RENOVA | Bausch Health Companies | N-021108 RX | 2000-08-31 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VELTIN | Almirall | N-050803 RX | 2010-07-16 | 1 products, RLD, RS |
ZIANA | Bausch Health Companies | N-050802 RX | 2006-11-07 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TWYNEO | Mayne Group | N-214902 RX | 2021-07-26 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
011010 niacinamide 4% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
011013 niacinamide 4% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
011020 niacinamide 4% / tretinoin 0.05% | unapproved drug other | 2020-07-02 |
011021 niacinamide 4% / tretinoin 0.05% | unapproved drug other | 2020-07-02 |
011218 niacinamide 2% / spironolactone 5% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
011220 niacinamide 2% / spironolactone 5% / tretinoin 0.05% | unapproved drug other | 2020-07-02 |
altreno | New Drug Application | 2020-03-02 |
ascorbyl palmitate 2% / hyaluronic acid sodium salt 0.2% / niacinamide 5% / tretinoin 0.025% | unapproved drug other | 2019-05-17 |
atracurium besylate | ANDA | 2024-12-04 |
atralin | New Drug Application | 2024-02-01 |
Expiration | Code | ||
---|---|---|---|
BENZOYL PEROXIDE / TRETINOIN, TWYNEO, GALDERMA LABS LP | |||
2024-07-26 | NC |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Tretinoin, Altreno, Dow Pharm | |||
10653656 | 2038-08-22 | DP | U-2368 |
11324710 | 2038-08-22 | U-2368 | |
Benzoyl Peroxide / Tretinoin, Twyneo, Galderma Labs Lp | |||
10420743 | 2038-07-12 | U-3194 | |
10653899 | 2030-12-30 | DP | U-3194 |
11071878 | 2030-12-30 | DP | |
9868103 | 2028-08-08 | DP | U-3194 |
8617580 | 2028-02-03 | DP | |
Fluocinolone Acetonide / Hydroquinone / Tretinoin, Tri-Luma, Galderma Labs Lp | |||
7915243 | 2023-09-08 | DP | |
7939516 | 2023-09-08 | DP |
Code | Description |
---|---|
S0117 | Tretinoin, topical, 5 grams |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 21 | 34 | 23 | 6 | 8 | 81 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | 11 | 6 | 13 | 20 | 5 | 52 |
Promyelocytic leukemia acute | D015473 | — | C92.4 | 3 | 17 | 15 | 6 | 4 | 43 |
Scabies | D012532 | — | B86 | 2 | 4 | 10 | 2 | 3 | 21 |
Lice infestations | D010373 | — | B85.2 | 1 | 2 | 6 | 2 | 3 | 14 |
Covid-19 | D000086382 | — | U07.1 | 2 | 6 | 2 | 2 | — | 11 |
Recurrence | D012008 | — | — | 6 | 2 | — | 1 | 2 | 11 |
Melanosis | D008548 | EFO_0003963 | L81.1 | 1 | 2 | 1 | 4 | 4 | 11 |
Malaria | D008288 | EFO_0001068 | B54 | — | — | 1 | 1 | 7 | 9 |
Skin aging | D015595 | EFO_0005422 | — | — | 1 | 2 | 1 | 4 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 17 | 16 | 10 | — | 4 | 40 |
Myeloid leukemia | D007951 | — | C92 | 17 | 15 | 10 | — | 3 | 38 |
Neuroblastoma | D009447 | EFO_0000621 | — | 10 | 20 | 9 | — | 2 | 38 |
Myelodysplastic syndromes | D009190 | — | D46 | 13 | 14 | 4 | — | — | 24 |
Preleukemia | D011289 | — | — | 11 | 12 | 4 | — | — | 22 |
Syndrome | D013577 | — | — | 11 | 11 | 4 | — | — | 22 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 8 | 2 | — | — | 11 |
Carcinoma | D002277 | — | C80.0 | 3 | 4 | 2 | — | — | 9 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 3 | 1 | — | 2 | 8 |
Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | — | 4 | 2 | — | 1 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 9 | 4 | — | — | — | 11 |
Multiple myeloma | D009101 | — | C90.0 | 8 | 7 | — | — | — | 11 |
Plasma cell neoplasms | D054219 | — | — | 8 | 7 | — | — | — | 11 |
Lymphoma | D008223 | — | C85.9 | 6 | 4 | — | — | — | 9 |
Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 6 | 3 | — | — | — | 7 |
Melanoma | D008545 | — | — | 4 | 6 | — | — | — | 6 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | 1 | — | — | — | 5 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 4 | 2 | — | — | — | 5 |
Hodgkin disease | D006689 | — | C81 | 2 | 3 | — | — | — | 5 |
Myelomonocytic leukemia acute | D015479 | — | C92.5 | 4 | 2 | — | — | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 4 | — | — | — | 1 | 5 |
Lymphoid leukemia | D007945 | — | C91 | 2 | — | — | — | 1 | 3 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 3 | — | — | — | — | 3 |
T-cell lymphoma cutaneous | D016410 | — | C84.A | 3 | — | — | — | — | 3 |
Acute disease | D000208 | — | — | 1 | — | — | — | 1 | 2 |
Primary myelofibrosis | D055728 | — | D47.4 | 2 | — | — | — | — | 2 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | — | — | — | — | 2 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 2 | — | — | — | — | 2 |
Burkitt lymphoma | D002051 | — | C83.7 | 2 | — | — | — | — | 2 |
Plasmablastic lymphoma | D000069293 | — | C83.3 | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | — | — | — | — | 7 | 7 |
Vasculogenic impotence | D018783 | EFO_1001234 | — | — | — | — | — | 5 | 5 |
Allergic rhinitis | D065631 | — | J30.9 | — | — | — | — | 2 | 2 |
Rhinitis | D012220 | EFO_0008521 | J31 | — | — | — | — | 2 | 2 |
Tick-borne diseases | D017282 | — | — | — | — | — | — | 2 | 2 |
Tick bites | D064927 | — | — | — | — | — | — | 2 | 2 |
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | — | — | — | 2 | 2 |
Rupture | D012421 | — | — | — | — | — | — | 2 | 2 |
Pigmentation | D010858 | CHEBI_26130 | — | — | — | — | — | 2 | 2 |
Respiratory tract infections | D012141 | — | J06.9 | — | — | — | — | 1 | 1 |
Drug common name | Tretinoin |
INN | tretinoin |
Description | All-trans-retinoic acid is a retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry. It has a role as a keratolytic drug, an antineoplastic agent, an antioxidant, a signalling molecule, a retinoid X receptor agonist, an anti-inflammatory agent, an AP-1 antagonist, a retinoic acid receptor agonist and a human metabolite. It is a retinoic acid and a vitamin A. It is a conjugate acid of an all-trans-retinoate. |
Classification | Small molecule |
Drug class | retinol derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 |
PDB | — |
CAS-ID | 302-79-4 |
RxCUI | — |
ChEMBL ID | CHEMBL38 |
ChEBI ID | 15367 |
PubChem CID | 444795 |
DrugBank | DB00755 |
UNII ID | 5688UTC01R (ChemIDplus, GSRS) |